Daphne Koller Wants to Fix Drug Discovery With A.I.—and Real Data Insitro's co-founder is betting on the fact that real progress in biotech requires more than clever algorithms. By The Editors
100 Leaders Shaping the Future of Artificial Intelligence They write the script that the rest of us follow. By The Editors
Christie’s and Sotheby’s Close 2025 With a Market Rebound Fueled by Luxury and New Buyers By Elisa Carollo
A Tribute to Luigi Bonotto, the Visionary Fluxus Patron Who Merged Art, Life and Industry By Elisa Carollo
A.I. Is Overhyped Yet Underappreciated, Says DeepMind CEO Demis Hassabis By Alexandra Tremayne-Pengelly
Museum of Tomorrow’s Fábio Scarano On Rethinking Science Through Art and Redefining Institutional Purpose By Dan Duray